25-sekundowy test na obecnść koronawirusa
EN_01476477_0001
=EDITORIAL USE ONLY. MATERIALS ONLY TO BE USED IN CONJUNCTION WITH EDITORIAL STORY. THE USE OF THESE MATERIALS FOR ADVERTISING, MARKETING OR ANY OTHER COMMERCIAL PURPOSE IS STRICTLY PROHIBITED. MATERIAL COPYRIGHT REMAINS WITH BRITISH AIRWAYS.
British Airways is the first airline in the world to conduct a trial with medical tech company Canary Global, to assess how its Pelican Covid-19 Ultra Rapid Covid-19 test, which displays a result within 25 seconds, can play a role in opening up travel. The airline will be inviting flight and cabin crew to take the Pelican Covid-19 test and will compare the performance of the result against existing tests that they are already taking. Recently approved for use in Europe and UK, the test is currently going through U.S. FDA approval and the airline is the first in the world to trial the new technology. Subject to successful evaluation the airline hopes to be able to offer the test technology on applicable routes where tests have to meet the stated specificity and sensitivity standards. The test is a non-invasive saliva ultra-rapid digital antigen test that delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2. Users simply take a sample of their saliva into a disposable sensor unit, shake and insert it into a re-usable digital reader which is connected to a blue-tooth enabled device like a smartphone, and then wait for the results that appear through a mobile app. The test which probes for both the S and N SARS-Cov-2 protein is optimized to detect variants that have originated across the globe. Sean Doyle, British Airways??? Chairman and CEO, said: ??sAs we start to see the opening up of travel we remain committed to exploring easy and affordable testing solutions to help our customers travel again, whether it???s for business, to reunite with family and friends or take a much-needed break abroad. We think this new ultra-rapid test is a game changer so we are delighted to work with the team at Canary to begin initial trials with our flight and cabin crew, before exploring what role it could play as a customer testing option.??? Raj Reddy, Canary???s CEO and inventor of the technology said: ??sCombining the po
2021-05-14
Cover Images/East News
Cover Images
coverimages41426437
0,3MB
25cm x 17cm przy 300dpi
100, 25, 98, A, ABLE, ABROAD, ACROSS, AFFORDABLE, AGAIN, AGAINST, AIRLINE, AIRWAYS, ALREADY, AND, ANTIGEN, APP, APPEAR, APPLICABLE, APPROVAL, APPROVED, ARE, AS, ASSESS, ASYMPTOMATIC, AT, BE, BEFORE, BEGIN, BLUE-TOOTH, BOTH, BREAK, BRITISH, BUSINESS, CABIN, CAN, CANARY, CEO, CHAIRMAN, CHANGER, COMMITTED, COMPANY, COMPARE, CONDUCT, CONNECTED, CORONAVIRUS, COULD, COVID-19, CREW, CURRENTLY, CUSTOMER, CUSTOMERS, DELIGHTED, DELIVERS, DETECT, DEVICE, DIGITAL, DISPLAYS, DISPOSABLE, DOYLE, EASY, ENABLED, EUROPE, EVALUATION, EXISTING, EXPLORING, FAMILY, FDA, FEATURE, FIRST, FLIGHT, FOR, FRIENDS, GAME, GLOBAL, GLOBE, GOING, HAVE, HELP, HOPES, HOW, IN, INDIVIDUALS, INITIAL, INSERT, INTO, INVENTOR, INVITING, IS, IT, ITS, LIKE, MEDICAL, MEET, MOBILE, MUCH-NEEDED, NEW, NON-INVASIVE, OF, OFFER, ON, OPENING, OPTIMIZED, OPTION, OR, ORIGINATED, OUR, PELICAN, PERFORMANCE, PLAY, PO, PROBES, PROTEIN, RAJ, RAPID, RE-USABLE, READER, RECENTLY, REDDY, REMAIN, RESULT, RESULTS, REUNITE, ROLE, ROUTES, SAID, SALIVA, SAMPLE, SARS-COV-2, SAS, SCOMBINING, SEAN, SECOND, SECONDS, SEE, SENSITIVITY, SENSOR, SHAKE, SIMPLY, SMARTPHONE, SO, SOLUTIONS, SPECIFICITY, STANDARDS, START, STATED, STORY, SUBJECT, SUCCESSFUL, SYMPTOMATIC, TAKE, TAKING, TEAM, TECH, TECHNOLOGY, TEST, TESTING, TESTS, THAT, THE, THEIR, THEN, THEY, THINK, THIS, THROUGH, TO, TRAVEL, TRIAL, TRIALS, U, UK, ULTRA, ULTRA-RAPID, UNIT, UP, USE, USERS, VARIANTS, WAIT, WE, WHAT, WHERE, WHETHER, WHICH, WILL, WITH, WITHIN, WORK, WORLD,